News Hub | News Direct

BNB Loses Market Interest, Solana and 100x Altcoin Raboo Steal the Spotlight

Total Media

The cryptocurrency market has experienced a series of bullish and bearish trends from a couple of major coins. With Solana demonstrating a massive recovery trajectory and BNB price moving sluggish, investors seem to be losing interest in BNB and pivoting to the newly created socialFi meme coin. Raboo is a brand-new SocialFi coin created with a combination of top-notch technology and a splash of amazing meme-hunting skills. This coin has stolen the spotlight as it is predicted to surge up to 233% in 2024. Raboo, currently in Stage 4 of its presale phase, and raking in over $1.6million so far, it’s projected by analysts to surge up 100x on launch day. In this article, we will talk more about all you need to know regarding the progress of this coin. BNB: Massive Decline in Market Price of Binance Coin Recently, the value of BNB had experienced a downward trend of about eight percent in comparison with the dollar value. This shows clearly that the token isn't going to bring in big ROI, causing investors to lose interest in the market coin. BNB has had a bullish short-term trend, rising fourteen percent during the last couple of months, analysts warn of BNB as it is approaching its resistance of $645.02. BNB is Currently trading at $621.05 with a trading volume of approximately $2.8 billion, and YTD value of only 100%. A Crypto analyst recently described the Binance Coin as having a bullish past, with a bearish future. Due to its recent performance, investors are now seeking other alternatives to dive into, with Raboo’s presale coin showing potentials of up to 100x its market value. Solana is predicted to surge by 10% in The Crypto Market The debut of meme-coins on the Solana blockchain has been met with excitement from investors. Using the unrestricted nature of blockchain technology, Solana is an open-source project with a huge operation that provides DeFi solutions. Solana Enthusiast projects that there is a high chance it will experience a bullish trend of up to 10% in the next couple of days. This is due to the increase in its overall trading volume and market cap. In the last 24 hours, Solana has had a trading volume of approximately $2.1 billion and a market price of $75.5bn. Raboo’s Bright Future of Up to 100x is Still Bringing in Investors Raboo is predicted to place among the top AI-themed meme coins in 2024, and it definitely has people talking. The price of the presale token is estimated to go up to 233%, following its starting price of $0.003 Currently in Stage 4 with a price of $0.0048.. In a market where investors are shifting toward meme coins, Raboo is a top-tier native token that has the potential to surge by 10,000% upon its listing on a major exchange platform. Raboo offer holders the opportunity to experience the combination of MemeFi, blockchain, and SocialFi. Enthusiasts get to benefit from the special social-fi model and earn more tokens by participating in weekly, monthly, and quarterly competitions. The new meme coin is driving the $62 billion meme market and without a doubt one of the best altcoin to invest in. Conclusion In the cryptocurrency space, not only Solana but also Binance Coin have experienced big hits. With the increase in solana trading volume and market cap, it’s expected to experience a 10% surge in the couple of days. Meanwhile, Raboo is stealing the spotlight following its prediction of reaching up to 100x its current price, investors are now finding their way to this AI-powered meme coin. You can participate in the Raboo presale here. Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 04, 2024 08:24 AM Eastern Daylight Time

Image

Novus Reports Q1 Results And Key Success Factors Following DEA Rescheduling

Novus Acquisition & Development Corp

Miami, Florida - ( ThriveNewsWire ) - Novus Acquisition & Development Corp d/b/a Novus Cannabis MedPlan (OTC Markets: ( NDEV ) is a leading national supplemental health insurance carrier and pioneer in offering cannabis in health plans for recreational and medicinal users. It released its update on its Q1 2024 results, Rx Dispensing Platform, and Key Elements that fuel its success after the Drug Enforcement Agency (DEA) announced that cannabis will be rescheduled. Novus Cannabis MedPlan (Novus) has been integrating cannabis into health plans since 2015. With a network of over 1,200 agents, brokers, and dispensaries, Novus aims to make cannabis-based treatments more affordable and accessible through insurance plans, benefitting a wider range of consumers. Here are three key highlights that contribute to Novus' success. 1) Financial Snapshot: The company utilizes a receivable-based business model with minimal overhead and no convertible debt, demonstrating consistent organic growth year over year. No Dilution: No common stock has been issued after June 15, 2021. No Sales of Insider Shares: For close to 3 years Gross Revenue Increase: During this reporting period, Gross Revenue increased by 6.8% compared to March 31, 2024 and 2023, respectively, Net Revenue Increase: During this reporting period, EBITDA increased by 19.47% compared to March 31, 2024, and 2023. Profit Margin: During the reporting period, the company experienced a gradual increase in gross profit margins, with margins of 43.14% in 2023 and 45.2% in 2024 Cash and Cash Equivalents: There was an increase of 1.8% compared to the financial reporting periods on March 31, 2024, and December 31, 2023. This is in contrast to the higher increase of 6.84% in the period from March 31, 2023, to 2024. Debt Transparency: Frank Labrozzi, the CEO, is owed $158,061. He has no plans to exercise the call provision, and this debt instrument has no equity conversion provision. Leak Out Vendor Shares: All vendors who received treasury-issued stock must gradually sell their shares. The selling amount is determined based on 15% of the average daily trading volume over the past 30 days. 2) Introducing the Rx Dispensing Platform Novus is strategically positioning its cannabis health plans to become a prominent player in mainstream healthcare insurance by acquiring an Rx Dispensing Platform tech stack. Frank Labrozzi, CEO of Novus, stated, "This advancement will significantly impact cannabis in health plans. By promoting collaboration between brands and dispensaries, we aim to empower policyholders with more choices, enabling them to purchase the brands they prefer at any dispensary. Cannabis brands can use the platform to connect directly with dispensaries and showcase their products at no cost. This will improve product distribution efficiency, increase brand visibility, provide real-time inventory data, and facilitate product research for the policyholder. An added bonus to For Rec Users: This platform serves recreational users who prefer not to disclose personal information like their policyholder status to access plan benefits. Instead, users can discreetly order services for a small subscription or transaction fee. 3) Key Success Factors Midwest Expansion: Novus has partnered with Heya Wellness, a prominent cannabis company in Missouri, to offer MedPlans to 4.3 million potential policyholders in the Midwest. By leveraging Missouri's favorable reciprocity laws, Novus aims to maximize the benefits for our sales hub based in St. Louis. Health Carrier Alliances Integration with Traditional Healthcare: By treating cannabis as a traditional pharmaceutical product and including it in insurance plans, Novus could help normalize cannabis use for medical, recreational, and non-users. Now that there is federal approval, Novus bridges traditional healthcare and the cannabis industry, enhancing major healthcare carriers who have expressed interest in integrating Novus' cannabis-based prescription plans into their benefits packages, establishing a connection between the two industries. Compassionate Care Act (CCA): The CCAs, which the Supreme Court sanctions, typically focus on making medical marijuana accessible to workplace patients with specific conditions. Human Resources departments are revising workplace policies to allow employees to access medical marijuana through employer-sponsored health plans. Novus plans to cover some costs through tax-deductible health savings and health reimbursement accounts. Opioid Settlement Framework: The opioid settlement framework is a legal agreement aimed at resolving litigation against pharmaceutical companies and health carriers accused of contributing to the opioid crisis. It includes $50 billion for prevention, treatment, and recovery programs with the goal of mitigating the crisis' impact and preventing future misuse. Novus is playing a crucial role in reducing opioid use by offering states and private organizations alternative treatment options through our developed health plans that help patients transition from opioids to medical cannabis. Compliance with the Veteran’s Affairs (VA): Veterans are increasingly interested in utilizing cannabis for treatment—over 88% support medical cannabis programs. Novus has developed health plans following VA guidelines to integrate cannabis benefits for veterans. In closing: As Novus adjusts to the positive changes in federal cannabis regulation, we are prepared to utilize our niche approach to cannabis in health plans, which utilizes a receivables-based business model. This approach strategically enables us to organically invest in critical areas such as marketing, improving engagement with policyholders and providers, and establishing a reliable cash flow management system. This positions Novus as a significant player in the fast-evolving cannabis integrated into health insurance plans. Do your research on our company to understand our potential in shaping the future of healthcare. Visit our Investor Relations page to see for yourself. About Novus Further Research: Financial Filings: Click Here Quote: Click Here Website Click Here Investor's Page Click Here Video Of Investment Highlights: Click Here Novus Acquisition & Development Corp. (NDEV) operates through its subsidiary, WCIG Insurance Services, Inc., offering health insurance and related insurance solutions in states with legal medical marijuana programs. With a robust infrastructure covering various insurance lines, including health, life, and fixed annuities, Novus is a leading health insurance carrier, using two key indicators to gauge value and performance. The Benefit Monetization Ratio measures the annual total of monetized policies, offset by the operating cost ratio, a Balance Sheet line item derived from Net Asset Value and calculated to the Price Book Value. Novus' medical cannabis benefits package operates as an outside developer. It does not engage in any activities related to the cultivation, handling, transportation, growth, extraction, dispensing, sale, marketing, vending, delivery, supply, circulation, or trade of cannabis or any substances violating United States law or the Controlled Substances Act. The company adheres strictly to state and federal laws and has no intentions to violate them in the future. It is important to note that statements regarding specific products have not been evaluated by the United States Food and Drug Administration (FDA) and should not be interpreted as intended to diagnose, treat, cure, or prevent disease. The information provided in press releases and product labels is for informational purposes only and should not be considered a substitute for advice from qualified healthcare professionals. Novus respects the individual transactions involving cannabis, which are solely between state-licensed dispensaries and registered patients. However, it's worth noting that state laws may conflict with the federal Controlled Substances Act. The current administration has indicated that federal law enforcement agencies will not prioritize prosecuting those complying with state-designated laws concerning medical marijuana usage and distribution. Nevertheless, changes in government policies and consolidation could impact the provider network, and there is no assurance that future administrations will not alter this stance. While Novus does not engage in the harvest, distribution, or sale of cannabis or cannabis-related products, the company could be affected if there were any shifts in enforcement by federal or state governments concerning existing laws. Such changes could result in significant financial implications for Novus and other industry players. Forward-Looking Statements This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. Investor Contact Information Investor Website 855-228-7355 Email: pr@getnovusnow.com Contact Details Novus Acquisition Frank Labrozzi +1 305-467-6699 frank@ndev.biz Company Website https://getnovusnow.com/

June 04, 2024 08:00 AM Eastern Daylight Time

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced at BIO International the completion of its new manufacturing building at the AGC Biologics Copenhagen campus. The completed work doubles the site’s single-use bioreactor capacity for mammalian services and allows it to produce 150 more batches of drug product each year. The expansion adds 19,000 m2 of space in an ultramodern building that houses a large manufacturing floor, expanded quality control and process development lab space, utilities to support all operations and prevent outages caused by natural disasters, and a fully dedicated warehouse to serve the entire AGC Biologics Copenhagen campus. The new AGC Biologics Copenhagen manufacturing building is already in production with its first customer, a phase II/III clinical product. AGC Biologics announced the planned expansion in November 2020, investing roughly $200 million into the work. One-of-a-kind single-use manufacturing offering The new manufacturing area offers 8 x 2,000 L single-use bioreactors with two seed trains, as well as two independent downstream suites – [CW1] more than doubling the existing capacity offered at this site for mammalian-based projects. AGC Biologics Copenhagen is now one of the only sites in the world with multiple single-use bioreactor systems of this magnitude capable of producing batches at high-levels of clinical and commercial production. Further, for developers needing to transfer in an existing process, AGC Biologics Copenhagen’s multiple single-use suites give the site greater flexibility to take on technical transfers and perform like-for-like process and knowledge activities for products entering the facility, eliminating lag time associated with onboarding a new CDMO. AGC Biologics has been a leader in single-use technology over the last decade, and it is one of the largest CDMO networks in the industry offering flexible and scalable single-use bioreactors systems. The news comes after AGC Biologics announced an end-to-end protein biologics drug product partnership with Dutch-based BioConnection in late May. The alliance provides a secure and full-service “gene-to-vial” offering for biopharma developers with drug substance development, manufacturing and aseptic fill and finish capabilities for drug products. “AGC Biologics Copenhagen site continues to be one of the most active in our network with all the necessary commercial approvals – FDA, EMA, HCA, PMDA, ANVISA etc. – and we are more than happy to offer the capacity and capabilities our current and future customers will look for with this completed expansion,” said Christoph Winterhalter, CBO, AGC Biologics. “The expansion, combined with our new drug product alliance, demonstrates AGC Biologics’ agility to meet all the needs developers may have, from pre-clinical through commercial.” AGC Biologics’ Copenhagen site core teams of scientists have more than 25 years of expertise in biopharmaceutical development and manufacturing, including seven commercial products brought to market. The site offers pre-clinical through commercial production for protein biologics services using mammalian and microbial systems. It has a gold EcoVadis Sustainability Rating for its environmental, health and sustainability practices. “I am extremely proud of the work and collaboration of everyone at our site over the last several years, it is truly remarkable to see what we can accomplish by working together. We are eager to offer more of the important capabilities the industry is looking for to support patients in need,” said Andrea C. Porchia, General Manager, AGC Biologics Copenhagen. To learn more about AGC Biologics Copenhagen, visit www.agcbio.com/facilities/copenhagen. For more information about AGC Biologics’ global CDMO services go to www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

June 04, 2024 12:00 AM Pacific Daylight Time

Mphasis and Classiq Partner to Drive Quantum Innovation

Classiq Technologies

Mphasis, (BSE: 526299; NSE: MPHASIS), an Information Technology (IT) solutions provider specializing in cloud and cognitive services, today announced its strategic partnership with Classiq, a leading quantum software company to demonstrate and commercialize industry solutions powered by Quantum. The strategic partnership aims to accelerate the adoption of quantum solutions for enterprises by integrating them into its operations. The collaboration is committed to fostering innovation and redefining technological boundaries and paving the way for a quantum-powered future. Classiq leads in quantum computing software and has developed a platform for faster and more efficient quantum algorithm design. Mphasis will focus on building industry solutions in sectors such as BFSI, Lifesciences, Healthcare, Supply Chain & Logistics, Chemistry, utilizing these advanced algorithms. By leveraging Classiq’s quantum platform, Mphasis will develop industry-specific intellectual properties (IPs) and will also jointly market and implement customer IPs, execute customer projects, and provide support for the commercialization of Classiq’s platform and IPs. Additionally, Mphasis’ Quantum Initiative, launched in 2020 within the Applied R&D division, NEXT Labs, aims to facilitate our client's transition to the quantum era. The adoption model comprises awareness-building, assessment, and consulting workshops, as well as the development and implementation of quantum solutions in key domains such as optimization, artificial intelligence, simulation, and cybersecurity. Within the realm of quantum computing, the company’s priorities include applied research, the creation of industry-specific solutions and intellectual properties, thought leadership dissemination, building robust partnerships, and leveraging a design thinking approach to drive adoption. “We are thrilled to announce our collaboration with Classiq and leveraging their expertise to unlock the vast potential of quantum computing. This partnership enables us to combine our industry knowledge with cutting-edge quantum technology, to innovative solutions tailored to our clients' needs. Together we hope to lead the way in initiating and implementing state-of-the-art quantum solutions that redefine the boundaries of our field," said Srikumar Ramanathan, Chief Solutions Officer, Mphasis. "Classiq is proud to be partnering with Mphasis to support scalable enterprise quantum computing software development. Together we combine depth of industry domain knowledge and quantum expertise with the technology needed to implement sophisticated optimized quantum computing programs for our clients," said Nir Minerbi, CEO and Co-Founder, Classiq Technologies. By synergizing Mphasis' domain expertise with Classiq's quantum computing acumen, the collaboration is poised to unlock newer possibilities and redefine industry benchmarks. Quantum computing's ability to tackle previously unsolvable problems opens doors for entirely new discoveries and innovations. National Institute of Standards and Technology’s report states that quantum computing could lead to breakthroughs in areas like materials science, drug discovery, and financial modelling. McKinsey & Company estimates a $106B potential quantum technology market size by 2040. The alliance between Mphasis and Classiq represents a fusion of expertise and innovation, with Classiq's cutting-edge quantum development platform complemented by Mphasis' extensive industry knowledge. Together, the companies aim to pioneer groundbreaking quantum solutions that will reshape sectors primed for transformative change. Classiq’s platform enables both beginner and expert designers to rapidly generate, analyze, and execute quantum circuits. The collaboration reflects the shared dedication of Mphasis and Classiq, showcasing a commitment to pioneering quantum computing applications across diverse industry sectors. Apart from this, in June 2021, Mphasis along with the Government of Alberta, and the University of Calgary signed an MoU to announce the launch of the world-leading Quantum City - Canada. The strategic partnerships were to accelerate talent development and the development of a quantum computing ecosystem in Calgary, driving R&D in the technology sector. In June 2022, Mphasis deepened its commitment to Canada by announcing a delivery center in Calgary, opening the center in Alberta for business. The Mphasis business ecosystem was positioned to reinforce the region's reputation as a leading hub for digital transformation, AI, quantum computing, and more, and contribute to Canada's growing digital sector. About Mphasis Mphasis’ purpose is to be the “Driver in Driverless Car” for Global Enterprises by applying next-generation design, architecture, and engineering services, to deliver scalable and sustainable software and technology solutions. Customer centricity is foundational to Mphasis, and is reflected in the Mphasis’ Front2Back ™ Transformation approach. Front2Back™ uses the exponential power of cloud and cognitive to provide hyper-personalized (C= X2C2TM =1) digital experience to clients and their end customers. Mphasis’ Service Transformation approach helps ‘shrink the core’ through the application of digital technologies across legacy environments within an enterprise, enabling businesses to stay ahead in a changing world. Mphasis’ core reference architectures and tools, speed and innovation with domain expertise and specialization, combined with an integrated sustainability and purpose-led approach across its operations and solutions are key to building strong relationships with marquee clients. Click here to know more. ( BSE: 526299; NSE: MPHASIS ) About Classiq Classiq Technologies, the leading quantum software company, provides an all-encompassing software platform (IDE, compiler and OS) with a single point of entry into quantum computing, from algorithm design to execution. Tailored to all levels of developer proficiency, Classiq aims to democratize access to quantum computing with software that equips customers to take full advantage of the quantum computing revolution. A low-code development environment that automates quantum programming ensures that a broader range of talents, including those with backgrounds in AI, ML and linear algebra, can harness quantum computing without requiring deep, specialized knowledge of how to program quantum computer hardware. Classiq also works closely with advanced computation hardware providers providing software for use with quantum computers, HPC and quantum simulators. Backed by powerful investors such as HPE, HSBC, Samsung, Intesa Sanpaolo and NTT, Classiq’s world-class team of scientists and engineers has distilled decades of quantum expertise into its groundbreaking software development platform. Follow Classiq on LinkedIn, X (formerly Twitter) or YouTube, join the Slack community, or try the Classiq platform. Contact Details Rainier Communications Michelle Allard McMahon +1 781-718-3248 classiqPR@rainierco.com Mphasis Corporate Communications Deepa Nagaraj +1 646-424-5160 deepa.nagaraj@mphasis.com Mphasis Corporate Communications Sumana Bhat +91 99029 80980 sumana.bhat@mphasis.com Company Website http://www.classiq.io/

June 04, 2024 02:04 AM Eastern Daylight Time

News Release

Dentakay Launches Comprehensive Guide on Dental Implant Procedures.

Rev Up Marketers

Dentakay is a well-established dental clinic in Istanbul. In the recent record, the company has announced the launch of its latest offering, a detailed guide titled “Dental Implant Procedures: What to Expect Post-Surgery”. The newly released guide is aimed at providing invaluable insights into the post-operative phase following dental implant procedures, this guide serves as an indispensable resource for patients, particularly those traveling from abroad to seek dental care in Turkey. Crafted by expert dentists with a wealth of experience in dental implantation, the guide delves into essential steps and precautions for optimal healing post-surgery. It offers comprehensive aftercare instructions to help patients manage common symptoms such as swelling and bleeding effectively. Practical advice, including the application of ice packs to reduce swelling and the use of gauze pads or moistened tea bags to control minor bleeding, is provided to ensure a smooth recover journey. According to Wafaa, a senior representative for Dentakay, “ This guide addresses critical aspects of the post-surgery period, empowering patients with the knowledge and tools they need to navigate the recovery process with confidence. From dietary recommendations to lifestyle adjustments, it leaves no stone unturned in ensuring the patients receive the best possible care and support”. The guide also sheds light on the typical healing timeline, which can span up to six months depending on individual circumstance. Furthermore, it emphasizes the importance of lifestyle choices in the healing process, cautioning against the adverse effects of smoking, poor diet, and inadequate dental care. To aid patients in making informed dietary choices during the initial recovery phase, the guide includes nutritional guidance curated by dental experts. Wafaa added, " We encourage patients to take time off from work and ensure accompaniment if sedation will be used. With the guide, we aim to reassure patients and give them clear instructions to ensure they feel supported throughout their healing journey. It’s also critical to scheduling your dental implant procedure on time. Our team hopes it will help them realize the importance of caring for their teeth and follow-up appointments so they don't face any issues during their recovery." Consequently, Dentakay caters to a comprehensive range of dental treatments including dental implants, teeth whitening, dental crowns, orthodontics, jaw surgery, and pedodontics. About the Company – Dentakay Dentakay is a state-of-the-art dental clinic founded in 2009 and headquartered in Istanbul, Turkey. It is renowned for its commitment to excellence and patient-centered care. With a team of highly skilled dentists and innovative technologies, Dentakay starves to deliver necessary dental care solutions to patients worldwide. For further details, interested clients in accessing the guide and exploring other resources related to dental implant installations can visit the Dentakay’s official Website. Contact Details Dentakay Wafaa +90 546 559 41 48 Info@dentakay.com Company Website https://dentakay.com/

June 03, 2024 03:22 PM Eastern Daylight Time

Expert Predictions: 4 Cryptos Primed for Significant Upside

Blockchain Digest

ONDO, Rebel Satoshi ($RECQ ), Ethena (ENA), and Optimism (OP) are gaining traction as the four most lucrative crypto investments in the current market space. Let’s take a more detailed look at the facts and analyze how high these tokens could reach over the next crypto bull run! Experts Rank ONDO Among the Best Altcoins to Buy Now Analysts point out that the opening of the ONDO-PERP market on the Coinbase International Exchange enabled ONDO to reach a new record high of $1.32 on May 26. Furthermore, ONDO bulls are convinced that the token will manage to sustain its positive momentum and increase toward the $1.50 threshold in the following months. Experts single out ONDO’s significant surges in terms of its Total Value Locked (TVL) as another reason for this optimistic ONDO price prediction. Thus, ONDO is gaining traction as one of the best altcoins to buy before the next crypto bull run. On the other hand, some analysts expect pronounced drops in ONDO’s imminent market performance based on the token’s inability to provide valuable short-term returns. According to ONDO bears, holders can expect corrections toward the $0.80 mark by the end of the year. Traders Recognize $RECQ as a Formidable Force in the Crypto Meme Market Rebel Satoshi is a new meme coin project aiming to reshape the crypto landscape through its dedication to the decentralized revolution. On top of that, Rebel Satoshi users receive excellent rewards by contributing to the development of the platform’s vibrant two-token ecosystem. $RBLZ offers excellent real-world utility as Rebel Satoshi’s governance and membership token. Furthermore, the token raised over $2.5 million during the presale phase and is currently selling for $0.025 on the Uniswap DEX. Moreover, $RBLZ holders expect continued rallies in the forthcoming weeks, as the token’s current price marks a noteworthy 150% increase from the starting $0.010. Meanwhile, Rebel Satoshi’s second token, $RECQ, is at Stage 2 of the presale, available for only $0.0044. Thus, Stage 2 investors can expect 25% gains as early as the next presale stage and a remarkable 184% gain when $RECQ reaches its launch price of $0.0125. $RECQ serves as Rebel Satoshi ’s base currency for everyday transactions such as purchases, rewards, and fees. Furthermore, the powerful $RECQ token also provides access to Rebel Satoshi’s advanced buyback program and the numerous play-to-earn games in the fun-filled Rebel Satoshi Arcade. Make sure to chip in today, as $RECQ is set to continue its upward trend over the next crypto bull run! Ethena Emerges as One of the Top Altcoins to Buy in 2024 Ethena bulls suggest ENA as one of the top altcoins to buy now based on its excellent performance since its launch on April 2, 2024. While ENA recorded its all-time high of $1.51 on April 11, experts believe that Ethena could surpass the $1.70 price mark during the next crypto bull run. ENA traded at around $0.90 during the second half of May, meaning Ethena could increase by a remarkable 88.88%. Moreover, analysts point to Ethena’s various strategic partnerships as another important factor behind this bullish ENA price forecast. For example, Infinex announced its integration with Ethena Labs via an X post on May 28. However, Ethena bears warn that ENA’s failure to consolidate above the $1 threshold could announce the beginning of a lengthy downward trend. In the worst-case scenario, ENA could decrease by the year's close toward the $0.50 mark. Optimism Crypto Price Prediction: Could OP Surge To $3.60? Optimism enthusiasts believe that the next crypto bull run could help the OP token approach the $3.60 price level. OP traded around the $2.50 range during the final week of May, meaning OP investors could receive more than 44% gains. This bullish OP crypto price prediction is based on several factors, such as Optimism’s reputation as one of the leading L-2 scaling solutions. On the other hand, some experts have evaluated OP as a risky investment for the following term, as several Optimism whales have started to dump their OP holdings. Thus, Optimism bears claim that holders should expect corrections below the $2.20 range amid Optimism’s imminent price movements. Top market experts single out ONDO, ENA, OP, and $RECQ as the most rewarding options for the next crypto bull run, so don’t hesitate to join Rebel Satoshi’s mighty army of Recusants! For the latest updates and more information, be sure to visit the official Rebel Satoshi Website or contact Rebel Red via Telegram Contact Details Rebel Satoshi Rebel Red marketing@rebelsatoshi.com

June 03, 2024 02:50 PM Eastern Daylight Time

Image

XLB ETF: It’s Relevance to Increased Construction Activity

Select Sector SPDR

The United States has recently seen a resurgence in the construction industry. Investors aiming to benefit from this rise in construction activity may want to explore an exchange-traded fund (ETF), the Materials Select Sector SPDR Fund ( XLB ), which offers a snapshot of this bustling sector. As of the latest reports, the XLB ETF's strategic holdings reflect its commitment to offering diverse exposure within this thriving industry. Key Holdings Within XLB* XLB encompasses a diverse portfolio of businesses operating in different domains, including chemicals, construction materials, packaging and containers, metals and mining, along with paper and forest products. There are currently 28 companies in the portfolio. Leading the pack we have Linde PLC, a global leader in industrial gasses and engineering, at 21.45%. It is followed by Freeport-McMoRan Incorporated, a leading mining company, holding 7.19% of XLB. Next we have Sherwin-Williams, which is renowned for their excellence in paints, coatings, and related products, at 7.08%. Following is Ecolab, a prominent player in the industrial sector, making a significant contribution to XLB at 5.76%. Finally, there is Air Products and Chemicals, another key player in industrial gasses and related equipment, with 5.27%. This extensive coverage offers investors the opportunity to tap into numerous facets of the materials sector, proving advantageous during phases of economic expansion or heightened infrastructure investment. As the construction industry continues forward, XLB, with its 0.09% expense ratio**, remains well-positioned. Increasing Demand for Building Materials The steady demand for building materials has been a key factor in the growing relevance of XLB. As we continue to navigate the post-COVID-19 era, construction activities are on a significant rise, creating a surge in the need for raw materials. Furthermore, the increasing focus on infrastructure development is adding fuel to this rising demand. The recent passage of the infrastructure bill opens up avenues for substantial investments in diverse fields such as transportation, broadband, and clean energy, thereby making XLB a potentially attractive investment option. The Materials Select Sector SPDR Fund ( XLB ) provides diversified exposure to the thriving materials sector. With its current demand driven by ongoing construction projects and potential infrastructure expenditure, XLB emerges as a compelling choice for investors seeking to tap into these trends. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. *Holdings, Weightings & Assets as of 4/30/24 subject to change **Ordinary brokerage fees apply DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and non-diversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007537 EXP 7/31/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

June 03, 2024 02:25 PM Eastern Daylight Time

CvE Marketing Consultancy Welcomes Vanessa Miceli, New Global Data & Tech Practice Lead, Championing a New Era of Innovation

Goodway Group

CvE Marketing Consultancy is thrilled to announce the appointment of Vanessa Miceli as the new Global Data & Tech Practice Lead. Vanessa is a seasoned marketing leader with a career that spans over two decades, and whose expertise has been shaping the digital landscape since its inception as “new media.” She brings a wealth of experience from her valuable work with brands, start-ups, creative agencies, and media agencies. Vanessa has collaborated with several of the Fortune 100, driving go-to-market strategies, user acquisition, platform development, and optimal customer experiences with measurable success. In her new role, Vanessa is at the forefront of pioneering strategies for a cookie-less future, expanding CvE’s expertise in guiding clients through this evolving landscape. She is instrumental in strengthening the Tech & Data Practice, enriching it with a broader spectrum of martech and adtech platforms tailored to client needs. Vanessa’s vision and leadership are set to amplify the marketing consultancy’s presence, particularly among global clients with Marketing Analytics centers of excellence in the U.S., positioning CvE as a beacon of innovation and expertise in the marketing domain. “We are delighted to have Vanessa join our team,” said Paul Frampton-Calero, the Global President at CvE Marketing Consultancy. “Vanessa has established herself as a visionary solution architect and data strategist with her unique ability to synergize Marketing, IT, and Analytics enabling brands to build strategies that enhance customer experience and drive growth. Her appointment is a testament to our commitment to leading the charge in the ever-evolving role of marketing as a growth revenue engine for global brands.” In her previous role at Capgemini, Vanessa excelled at guiding marketing transformation engagements focused on customer experience and tech operations. She led audits, analyses, and workshops, creating roadmaps with tools like data platforms and interaction managers. Vanessa developed resources for the Customer First offerings, aiding clients’ shift to 1st party models and improving analytics. She also formed a team of experts in Customer Experience and Business Innovation. As a staunch advocate for women in technology, Vanessa is committed to breaking barriers and fostering an environment of inclusivity and empowerment. Her leadership is not only expected to propel CvE Marketing Consultancy service offering but also to inspire a new generation of data-driven marketers. About CvE Marketing Consultancy We are a consultancy dedicated to enabling marketing to be a more effective growth engine. Our team, comprised of industry experts and consultants with backgrounds spanning brand side, agency, technology, and publishing, advises Chief Marketing Officers (CMOs), senior marketers, and their teams on strategies that best suit their brand and business. We work with some of the world’s most progressive brands including Mars, Dell, Sainsbury's, 7-Eleven, Morrisons and Ulta Beauty. Contact Details Alexandra Morrison goodway@kitehillpr.com CvE Viviana Toro vtoro@controlvexposed.com Company Website https://controlvexposed.com/

June 03, 2024 02:00 PM Eastern Daylight Time

Game ON for Pakistan: Historic Talent Gathering for Game Developers, Animators, and Designers in Islamabad!

IDRAK AI

Islamabad, Pakistan – June 3, 2024 - ( ThriveNewsWire ) - Gaming industry in Pakistan has been on rise for last couple of years. Recently, number of major international investments in Pakistani Gaming tech sector have attracted attention of global tech players. The rising industry has experienced number of acquisitions of local talent in recent past. In this regard, the vibrant heart of Islamabad witnessed a landmark event as over 150 game developers, animators, and designers gathered for an unprecedented meetup. Hosted at the offices of IDRAK AI (Pakistan’s first award-winning AI company) and Design Peeps (a globally recognized leader in digital product design), the evening marked a pivotal moment for Pakistan’s gaming and animation industry. This historic event, organized by IDRAK AI and Design Peeps in collaboration with Arab Play, Miradore, Section Soft, Huawei, and Moonshot Animations, epitomized the spirit of innovation and partnership. Supported by P@SHA, IGI, and Maida Co., the meetup showcased the strength and diversity of Pakistan’s burgeoning creative and technological sectors. Throughout the evening, industry leaders shared profound insights into the current landscape and future prospects of game and animation development in Pakistan, facilitating a dynamic exchange of ideas and expertise. The event also witnessed the signing of three Memorandums of Understanding (MoUs) and two significant contracts, setting the stage for future collaborations in gaming, animation, mobile app development, and event management. These agreements are poised to propel the industry forward, targeting both local and Saudi market business segments. “We are elated by the extraordinary turnout and the enthusiasm from all sectors—government, academia, industry, and students alike,” said Sheikh Abdul Qadir, MD of IDRAK AI, and Usman Fiaz, CEO of Design Peeps, the visionary organizers behind the event, “This gathering is a testament to the immense potential and talent within Pakistan’s gaming industry. It’s truly Game ON for Pakistan.” The event was a celebration of the thriving community of game developers, animators, and designers. Attendees reveled in the vibrant atmosphere of Islamabad’s beautiful evening, engaging in discussions that spanned the latest technological innovations and the artistic nuances of game creation. The gaming industry in Pakistan, now valued at over half a billion dollar, demonstrated its significant growth and vast potential. This event stands as a milestone, heralding future growth and collaboration within the gaming and animation sectors. It created a crucial platform for stakeholders to unite, share knowledge, and drive the industry towards unprecedented heights. As Pakistan continues to make waves in the global gaming and animation markets, such events will be instrumental in fostering a robust and innovative ecosystem. Media Contact Bilal Wasti bilal@designpeeps.net For Further Information: - IDRAK AI: https://www.linkedin.com/company/idrakailtd/ - Design Peeps: https://www.linkedin.com/company/designpeeps/ Contact Details Design Peeps Bilal Wasti bilal@designpeeps.net Company Website https://idrakai.com/

June 03, 2024 12:27 PM Eastern Daylight Time

Image

All Industries

BNB Loses Market Interest, Solana and 100x Altcoin Raboo Steal the Spotlight

Novus Reports Q1 Results And Key Success Factors Following DEA Rescheduling

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

Mphasis and Classiq Partner to Drive Quantum Innovation

Dentakay Launches Comprehensive Guide on Dental Implant Procedures.

Expert Predictions: 4 Cryptos Primed for Significant Upside

XLB ETF: It’s Relevance to Increased Construction Activity

CvE Marketing Consultancy Welcomes Vanessa Miceli, New Global Data & Tech Practice Lead, Championing a New Era of Innovation

Game ON for Pakistan: Historic Talent Gathering for Game Developers, Animators, and Designers in Islamabad!